JAMA Oncology,
This nonrandomized phase 2 clinical trial evaluates the safety and feasibility of using magnetic resonance imaging criteria to…
This nonrandomized phase 2 clinical trial evaluates the safety and feasibility of using magnetic resonance imaging criteria to…
This phase II trial at high volume centers that selected “good risk” patients with stage II or III rectal cancer as defined by…
This nonrandomized phase 2 clinical trial evaluates the safety and feasibility of using magnetic resonance imaging criteria to…
Phase 2 trial of selecting pts w/”good risk” stage II or III rectal cancer by MRI at high volume centers reveals primary…